Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Falkenstein

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Topics in Behavioral Neurosciences|October 1, 2021
Chemical Probes for Histamine Receptor SubtypesMarkus Falkenstein, Milica Elek, Holger Stark
Bioorganic & Medicinal Chemistry|October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisationMarkus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of AutismNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Topics in Behavioral Neurosciences|October 1, 2021
Chemical Probes for Histamine Receptor SubtypesMarkus Falkenstein, Milica Elek, Holger Stark
Bioorganic & Medicinal Chemistry|October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisationMarkus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of AutismNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences|March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in MiceNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Pageof 1